Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
GLP-1 drugs consumer acceptance is changing rapidly
Why You Should Care The use of GLP-1s is about to explode in the U.S., and chances are good its going to impact your business
A new plan to lower the price of GLP-1s The Trump administration announced in early November that it had struck a deal with leading GLP-1 pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, to lower consumer prices for GLP-1 medications
That attention is understandable
Nationwide retrospective studies utilizing register data from Sweden and Denmark (20132021) and the UK CPRD (20072020) have revealed consistent findings, indicating that GLP-1 RAs are not associated with an elevated risk of suicidality relative to DPP-4 or SGLT-2 inhibitors [77,78]
US$ 22.43
US$ 20.62
US$ 25.99
